๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induction of alloreactive immunosuppression by 1,4-bis [(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)

โœ Scribed by Bosco Shang Wang; Araceli L. Lumanglas; Veronica M. Ruszala-Mallon; Roslyn E. Wallace; Frederick E. Durr


Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
564 KB
Volume
6
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Pharmacological disposition of 1,4-dihyd
โœ Katherine Lu; Niramol Savaraj; Ti Li Loo ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 328 KB

D HA Q, a new antitumor agent, has been selected for clinical trial on the basis of its activity against a number of transplantable rodent tumors. In anticipation of the clinical trial of this agent, the pharmacology of DHAQ was studied in beagles by high-pressure liquid chromatographic and radioche

Structure-activity relationship study of
โœ Robert K. Y. Zee-Cheng; C. C. Cheng ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

An oxygen analog of the antineoplastic anthraquinone, 1,4-dihydroxy-5,8-bis[ [2-(2-hydroxyethyl)amino]ethyl)amino -9,lO -anthracenedione, was synthesized. This compound, 1,4-dihydroxy-5,8bis[ [2-(2-hydroxyethoxy)ethyI]amino] -9,10-anthracenedione, was found to be inactive against P-388 lymphocytic l